Agomelatine

This classification denotes a serotonin antagonist and anxiolytic with the molecular formula C15H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 137R1N49AD, chemically known as acetamide, n-(2-(7-methoxy-1-naphthalenyl)ethyl)- but generally known as agomelatine, which bears US NIH Compound Identifier 82148. European Medicines Agency schedules Agomelatine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05286MIG. The term AGOMELATINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). World Health Organization schedules agomelatine in its Anatomical Therapeutic Chemical (ATC) Classification. AGOMELATINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule agomelatine under HS 29242995 and SITC 51479. As of Q4 2014, AGOMELATINE remains the US FDA Preferred Term for this commodity. Agomelatine bears US NLM identifiers UMLS ID C0971637 and NCI Concept Code C72684. SMILES: O(c1cc2c(CCNC(=O)C)cccc2cc1)C.